New vaccine combats gastroenteritis

GlaxoSmithKline has launched Rotarix, a live attenuated rotavirus vaccine, for the prevention of gastroenteritis due to rotavirus infection.

Rotarix is an oral vaccine indicated for infants from the age of six weeks. The vaccination course consists of two oral doses. The first dose is administered to infants from the age of six weeks, with the second dose being given after an interval of at least four weeks.

The vaccination course should preferably be given before 16 weeks of age, but must be completed by the age of 24 weeks.

Rotarix is presented as a powder and solvent for oral suspension. The cost of a single dose is £41.38.

Further information: GlaxoSmithKline, Stockley Park West, Uxbridge, Middlesex UB11 1BT. Tel: (0800) 221441.

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

More from MIMS

MHRA restricts indications for quinolone antibiotics following EU-wide safety review

MHRA restricts indications for quinolone antibiotics following EU-wide safety review

New restrictions and precautions for use have been...

Emollients, Potential Skin Sensitisers as Ingredients

Emollients, Potential Skin Sensitisers as Ingredients

Potential sensitising agents in emollient preparations.

Ophthalmic Preparations, Preservatives and Potential Sensitisers as Ingredients

Ophthalmic Preparations, Preservatives and Potential Sensitisers as Ingredients

Potential sensitising agents in eye drops and ointments.

Anti-Anginal Preparations, Summary by Pharmacological Class

Anti-Anginal Preparations, Summary by Pharmacological Class

Available formulations of anti-anginal drugs.